DMK Pharmaceuticals (GB:0A4X)

DMK Pharmaceuticals (0A4X) Cash flow


DMK Pharmaceuticals Cash Flow

GB:0A4X's free cash flow for Q2 2023 was $-2.57M. For the 2023 fiscal year, GB:0A4X's free cash flow was decreased by $16.91M and operating cash flow was $-2.57M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -13.19M$ -25.51M$ -37.79M$ -20.90M$ -19.89M$ -32.66M
Investing Cash Flow
$ 1.84M$ 3.41M$ 282.74K$ -946.21K$ -2.87M$ -3.54M
Financing Cash Flow
$ 3.01M$ 285.00K$ 53.94M$ 19.89M$ 12.29M$ 37.13M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 7.45M$ 1.12M$ 23.25M$ 6.75M$ 8.81M$ 19.27M
Income Tax Paid Supplemental Data
$ 26.00$ 3.65K$ 4.13K$ 9.40K$ 9.00K$ 5.61K
Interest Paid Supplemental Data
--$ 0.00$ 135.83K$ 106.78K$ 181.28K
Issuance Of Capital Stock
$ 2.38M-$ 51.75M$ 18.23M$ 13.80M$ 37.62M
Issuance Of Debt
--$ 1.77M$ 3.19M$ 0.00-
Repayment Of Debt
---$ -90.62K$ -496.79K$ -487.90K
Free Cash Flow
$ -9.38M$ -22.10M$ -39.01M$ -21.60M$ -22.75M$ -36.19M
Domestic Sales
Foreign Sales
Currency in USD

DMK Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis